Clinical trial

Optimum Dose of Remifentanil for Intubation in Small Children

NCT00474071 · University of British Columbia, Other · Completed

Key facts

NCT number NCT00474071
Title Optimum Dose of Remifentanil for Intubation in Small Children
Official title Investigation to Determine the Optimum Dose of Remifentanil for Tracheal Intubation in Children Using the Up/Down Method
Lead sponsor University of British Columbia, Other
Status Completed
Phase Phase 3
Study type Interventional
Conditions Endotracheal Intubation
Intervention type Drug
Interventions Remifentanil
Enrollment 60
Start date Mar 1, 2007
Primary completion Apr 1, 2008
Completion Apr 1, 2008
First posted May 16, 2007
Last update posted Sep 25, 2008
Countries Canada

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies